did serena williams use glp 1 Opens Up About Using a GLP-1 to Support Weight Loss Postpartum Serena Williams and the coming
Description
At this time, it is uncertain how participating beneficiaries will be able to maintain Medicare coverage of their GLP-1 medication for obesity after the Medicare GLP-1 Bridge ends at the end of 2027, pending further action from CMS to implement the BALANCE Model in Medicare Part D in 2028, as described below
Notes: Researchers are advised to adhere to the recommendations and not exceed the daily liraglutide dose of 3mg
16 , 17 Given this, the weight loss and metabolic improvements associated with GLP-1RA therapy may provide tangible benefits for this population
Xia J, Li Q, Liu Y, Ren Q, Gao J, Tian Y, et al
